Carcinogenesis, Vol. 20, No. 3, 373-382,
March 1999
© 1999 Oxford University Press
Accelerated Papers |
Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15
Institute of Medical Radiobiology, August Forel-Strasse 7, 8008 Zürich, Switzerland,
1 Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy,
2 Tumour Therapy Evaluation Laboratory, Paul Scherrer-Institute, 5232 Villigen, Switzerland and
3 Istituto di Ricerche di Biologia Molecolare `P.Angeletti', Via Pontina km 30 600, I-00040 Pomezia, Italy
Mismatch recognition in human cells is mediated primarily by a heterodimer of hMSH2 and hMSH6. Cells mutated in both alleles of the hMSH6 gene are deficient in the correction of base/base mispairs and insertion/deletion loops of one nucleotide and thus exhibit a strong mutator phenotype, evidenced by elevated mutation rates and microsatellite instability, as well as by tolerance to methylating agents. The decrease in replication fidelity associated with a loss of mismatch correction implies that with each division, these cells are likely to acquire new mutations throughout their genomes. Should such secondary mutations occur in genes linked to replication fidelity or involved in the maintenance of genomic stability, they might contribute to the observed mutator phenotype. The human colon tumour line HCT15 represents one such case. Although it carries inactivating mutations in both hMSH6 alleles, it has also been shown to contain a missense mutation in the coding sequence of the proofreading domain of the polymerase-
gene. In an attempt to find out whether the phenotype of HCT15 cells was indeed brought about solely by the lack of hMSH6, we stably transfected them with a vector carrying the wild-type hMSH6 cDNA. Our results show that although the levels of transgenic hMSH6 were low, expression of the wild-type protein resulted in a substantial restoration of mismatch binding, mismatch repair capacity and the stability of mononucleotide repeats, as well as in the reduction of mutation rates. Although methylation tolerance of the hMSH6-expressing cells was not markedly affected, the G2 cell cycle checkpoint, absent in N-methyl-N'-nitro-N-nitrosoguanidine-treated control cells, was restored.
Abbreviations: BrdU, 5-bromo-2'-deoxyuridine; DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethylsulphoxide; DTT, dithiothreitol; HNPCC, hereditary non-polyposis colon cancer; HU, hydroxyurea; IDL, insertion/deletion loop; MGMT, O6-methylguanine methyltransferase; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; MNU, N-methyl-N-nitrosourea; PBS, phosphate-buffered saline; PMSF, phenylmethylsulphonyl fluoride; pol, polymerase; RER, replication error in repeats; 6-TG, 6-thioguanine.
4 To whom correspondence should be addressed Email: jiricny{at}imr.unizh.ch
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Maxwell, S. P. Johnson, R. E. McLendon, D. W. Lister, K. S. Horne, A. Rasheed, J. A. Quinn, F. Ali-Osman, A. H. Friedman, P. L. Modrich, et al. Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma Clin. Cancer Res., August 1, 2008; 14(15): 4859 - 4868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Cahill, K. K. Levine, R. A. Betensky, P. J. Codd, C. A. Romany, L. B. Reavie, T. T. Batchelor, P. A. Futreal, M. R. Stratton, W. T. Curry, et al. Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment Clin. Cancer Res., April 1, 2007; 13(7): 2038 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Szadkowski, I. Iaccarino, K. Heinimann, G. Marra, and J. Jiricny Characterization of the Mismatch Repair Defect in the Human Lymphoblastoid MT1 Cells Cancer Res., June 1, 2005; 65(11): 4525 - 4529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Velangi, E. C. Matheson, G. J. Morgan, G. H. Jackson, P. R. Taylor, A. G. Hall, and J. A.E. Irving DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma Carcinogenesis, October 1, 2004; 25(10): 1795 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. E. Bechter, Y. Zou, W. Walker, W. E. Wright, and J. W. Shay Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells after Telomerase Inhibition Cancer Res., May 15, 2004; 64(10): 3444 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Russo, M. F. Blasi, F. Chiera, P. Fortini, P. Degan, P. Macpherson, M. Furuichi, Y. Nakabeppu, P. Karran, G. Aquilina, et al. The Oxidized Deoxynucleoside Triphosphate Pool Is a Significant Contributor to Genetic Instability in Mismatch Repair-Deficient Cells Mol. Cell. Biol., January 1, 2004; 24(1): 465 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Marra, S. D'Atri, C. Corti, L. Bonmassar, M. S. Cattaruzza, P. Schweizer, K. Heinimann, Z. Bartosova, M. Nystrom-Lahti, and J. Jiricny Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide PNAS, June 19, 2001; 98(13): 7164 - 7169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blake, J.-L. Tsao, A. Wu, and D. Shibata Stepwise Deletions of PolyA Sequences in Mismatch Repair-Deficient Colorectal Cancers Am. J. Pathol., May 1, 2001; 158(5): 1867 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Kleczkowska, G. Marra, T. Lettieri, and J. Jiricny hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci Genes & Dev., March 15, 2001; 15(6): 724 - 736. [Abstract] [Full Text]
|
|
|
|
|
|
H. Zhang, G. Marra, J. Jiricny, V. M. Maher, and J.J. McCormick Mismatch repair is required for O6-methylguanine-induced homologous recombination in human fibroblasts Carcinogenesis, September 1, 2000; 21(9): 1639 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ceccotti, C. Ciotta, G. Fronza, E. Dogliotti, and M. Bignami Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells Nucleic Acids Res., July 1, 2000; 28(13): 2577 - 2584. [Abstract] [Full Text] [PDF]
|
|